A resolution expressing support for the designation of July 2025 as "National Sarcoma Awareness Month".
- Bill Number
- S.Res. 299
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Passed Senate
- Latest Action
- 2025-06-24: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3520; text: CR S3518)
- Last Updated
- 2026-06-16T19:05:50Z
AI-Generated Summary
Purpose
This Senate resolution (S. Res. 299) expresses formal support for designating July 2025 as "National Sarcoma Awareness Month." Its main goal is to increase public awareness of sarcoma—a rare type of cancer affecting bones or connective tissues (like nerves, muscles, joints, fat, and blood vessels)—and to encourage early diagnosis and proper treatment.
Key Provisions
- Background on Sarcoma:
- Sarcoma can occur almost anywhere in the body and has over 70 subtypes.
- In the U.S., about 17,000 people are diagnosed yearly, 7,600 die from it annually, and around 50,000 are living with it at any time.
- It accounts for 1% of adult cancers and 15% of childhood cancers.
- Causes are not well understood, and it is often misdiagnosed or underreported.
- Treatments may include surgery, radiation therapy (using high-energy rays to target cancer cells), or chemotherapy (drugs to kill cancer cells).
- Designation Support: The Senate resolves to back July 2025 as National Sarcoma Awareness Month to promote education, diagnosis, and treatment.
Significant Changes to Existing Law
- This is a non-binding resolution, so it introduces no changes to existing laws or regulations. It serves as a symbolic statement of Senate endorsement rather than enforceable legislation.
Potential Impacts
- On Citizens: Could heighten public knowledge of sarcoma, leading to more people seeking timely medical check-ups and reducing misdiagnosis rates. It may support affected individuals and families by validating their experiences through national recognition.
- On Government Agencies: Minimal direct impact; agencies like the National Institutes of Health or Centers for Disease Control and Prevention might reference it in awareness campaigns, but no new funding or mandates are required.
- On International Relations: No notable effects, as this is a domestic awareness initiative focused on U.S. health issues.
Main Stakeholders Affected
- Patients and Families: The 50,000+ Americans living with sarcoma, including the 17,000 newly diagnosed each year, who may benefit from increased visibility and support.
- Medical Professionals: Doctors, oncologists (cancer specialists), and researchers who treat or study sarcoma, potentially seeing improved patient outcomes from better awareness.
- Public and Advocacy Groups: Non-profits and sarcoma foundations that organize events, as the designation could amplify their efforts during July 2025.
- General Public: All U.S. residents, encouraged to learn about this underrecognized cancer.
Notable Legal, Constitutional, or Political Implications
- Legal: As a simple resolution agreed to by the Senate on June 24, 2025, it has no legal force and does not require House approval or presidential signature. It cannot create obligations or allocate resources.
- Constitutional: Aligns with Congress's broad authority to express policy views under Article I, without infringing on individual rights or federal powers.
- Political: Represents bipartisan support for health awareness (submitted by Sen. Johnson), highlighting sarcoma's rarity and impact on children. It underscores Congress's role in promoting public health education but carries symbolic weight rather than substantive policy change.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Recent Actions
- 2025-06-24: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3520; text: CR S3518)
- 2025-06-24: Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.
- 2025-06-24: Introduced in Senate
Bill Versions
- Expressing support for the designation of July 2025 as National Sarcoma Awareness Month. — issued 2025-06-24 — PDF (2 pages)